Ashville Dental, Jeffrey L Angart, Dds, Inc | |
22 Miller Ave Ashville OH 43103-1273 | |
(740) 983-3151 | |
(866) 682-5140 |
Full Name | Ashville Dental, Jeffrey L Angart, Dds, Inc |
---|---|
Speciality | Dentist - General Practice |
Location | 22 Miller Ave, Ashville, Ohio |
Authorized Official Name and Position | Jeffrey L Angart (OWNER) |
Authorized Official Contact | 7409833151 |
Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
Mailing Address | Practice Location Address |
---|---|
Ashville Dental, Jeffrey L Angart, Dds, Inc 22 Miller Ave Ashville OH 43103-1273 Ph: (740) 983-3151 | Ashville Dental, Jeffrey L Angart, Dds, Inc 22 Miller Ave Ashville OH 43103-1273 Ph: (740) 983-3151 |
NPI Number | 1699900761 |
---|---|
Provider Enumeration Date | 05/19/2009 |
Last Update Date | 05/19/2009 |
Identifier | Type | State | Issuer |
---|---|---|---|
1699900761 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1223G0001X | Dentist - General Practice | 17627 (Ohio) | Primary |
News Archive
Neogenix Oncology, Inc. is pleased to announce it has signed an agreement with Cambridge Biomedical, Inc, based in Boston, MA, for the development of its pancreatic and colorectal cancer diagnostic serum ELISA assays.
Young adults with childhood history of both parental incarceration and juvenile justice involvement were nearly three times more likely to have depression or post-traumatic stress disorder compared to peers without any experience with the criminal justice system, according to a study published in JAMA Network Open.
Many children who suffer fingertip injuries have been abused, according to a Rutgers study. The researchers found that children who had a documented history of abuse or neglect were 23 percent more likely to suffer a fingertip injury before age 12.
PharmaNet Development Group, Inc., a leading provider of clinical development services to innovative pharmaceutical, biotechnology, generic drug and medical device companies, today announced that the United States Securities and Exchange Commission (SEC) has notified the Company that it has completed a two and half year investigation of the Company related to revenue recognition, earnings, company operations and related party transactions and does not intend to recommend any enforcement action by the Commission. The investigation, which is now closed, was originally initiated as an informal investigation in 2006 and became formal in March 2007.
Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, today announced that it has issued $6M in convertible notes and warrants to its Series A investors bringing the total investment to date to $55M. All current investors, including Domain Associates, MPM Capital, Avalon Ventures, Forward Ventures, Pappas Ventures and MC Life Sciences participated in the securities offering.
› Verified 9 days ago
Premier Dental Of Ashville Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 22 Miller Ave, Ashville, OH 43103 Phone: 614-425-9061 |